Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Monocentric, Open-label, Double-arm, Phase II Trial to Assess the Safety and Efficacy of Allogeneic Islet Cells Transplanted Into the Omentum

NCT02803905 is registered in ClinicalTrials.gov with Lorenzo Piemonti as lead sponsor.

NCT NCT02803905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02803905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Monocentric, Open-label, Double-arm, Phase II Trial to Assess the Safety and Efficacy of Allogeneic Islet Cells Transplanted Into the Omentum
Lead sponsor
Lorenzo Piemonti
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2016
Completion date
December 31, 2024
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, islets of langerhans transplantation